FDA Approved: LAMOTRIGINE EXTENDED-RELEASE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application to approve Lamotrigine Extended-Release from Par Health USA, LLC. The product's labeling covers indications for epilepsy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine Extended-Release (Lamotrigine extended-release)

Snippet

SUPPL AP for LAMOTRIGINE EXTENDED-RELEASE (LAMOTRIGINE)